Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2014-07-24EMA Withdrawn: Olanzapine Cipla (previously Olanzapine Neopharma) (olanzapine) — Cipla (EU) Limited
EMA withdrew Olanzapine Cipla (formerly Olanzapine Neopharma) in the EU; therapeutic areas include schizophrenia and bipolar disorder.
-
FDA approval · 2014-07-17FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for the PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE product from Mylan Pharmaceuticals Inc., in…
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: The Effectiveness of the Meta-cognitive Training Among Patients With Chronic Schizophrenia [NA]
The completed clinical trial assesses the effectiveness of meta-cognitive training in patients with chronic schizophrenia.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Decreased EEG Complexity in Schizophrenia
A completed clinical trial reports decreased EEG complexity in schizophrenia, with findings related to electrophysiological randomness and e…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Treatment of N-methyl-D-aspartate (NMDA) Enhancers for Schizophrenia [Phase 2]
A Phase 2 trial evaluating NMDA enhancers for schizophrenia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Varenicline and Smoking Cessation in Schizophrenia [Phase 2]
Phase 2 trial evaluating varenicline for smoking cessation in individuals with schizophrenia. Results were posted in 2014.
-
FDA approval · 2014-07-03FDA Approved: FLUPHENAZINE DECANOATE — Original Application (Endo USA, Inc.)
FDA approves a generic version of fluphenazine decanoate (long-acting injectable antipsychotic) under Original Application (ANDA) by Endo US…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Web-Based Weight Management for Individuals With Mental Illness [NA]
A completed clinical trial evaluating a web-based weight management program for individuals with mental illness, including schizophrenia.
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Treatment of Schizophrenia Through Internet-Based Psychoeducation [Phase 2]
Phase 2 clinical trial update on treating schizophrenia with internet-based psychoeducation; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Web-based Support for People With Schizophrenia and Their Families [NA]
A completed clinical trial evaluated a web-based support program for people with schizophrenia and their families. It examined its impact on…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Bioequivalence Fasting Study in Patients [Phase 2, Phase 3]
Amneal conducted a fasting-state bioequivalence study in schizophrenia patients; the Phase 2/3 trial has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug [Phase 4]
A Phase 4 trial comparing continuation of a prior antipsychotic versus switching to Paliperidone ER in schizophrenia patients unsatisfied wi…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia. [Phase 2]
Completed Phase 2 clinical trial evaluating RO4917838 in combination with antipsychotic treatment for schizophrenia.
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia [Phase 3]
Phase 3 study of paliperidone palmitate in Japanese patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia. [Phase 3]
This update concerns a Phase 3 study of paliperidone palmitate for preventing recurrence of schizophrenia symptoms. The trial status is comp…
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Cognitive Training to Improve Work Outcomes in Severe Mental Illness [Phase 2]
A Phase 2 clinical trial evaluating cognitive training to improve work outcomes in people with schizophrenia, bipolar disorder, or major dep…
-
CLINICAL_TRIALS research · 2014-06-17Clinical Trial Update: A Study to Assess Learning Performance in Patients With Schizophrenia and Young and Elderly Healthy Volunteers [EARLY_Phase 1]
This clinical trial update notes a completed EARLY_PHASE1 study by Janssen Research & Development to assess learning performance in individu…
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Effect of Motivational Therapy on Schizophrenia With Cannabis Misuse [NA]
A completed clinical trial evaluated Motivational Therapy for individuals with schizophrenia and cannabis use disorder.
-
CLINICAL_TRIALS research · 2014-06-16Clinical Trial Update: Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention [NA]
The document reports on a completed clinical trial examining a CBT-based intervention to improve medication adherence in individuals with sc…
-
CLINICAL_TRIALS withdrawal · 2014-06-12Clinical Trial Update: Glycine and D-Cycloserine in Schizophrenia [Phase 3]
Phase 3 trial evaluating glycine and D-cycloserine for schizophrenia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Enhancing the Prospective Prediction of Psychosis
A Yale University-sponsored study focusing on enhancing the prospective prediction of psychosis has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia [Phase 3]
This document reports results from a Phase 3 trial evaluating paliperidone for preventing relapse in people with schizophrenia. The results …
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896) [Phase 3]
Phase 3 fixed-dose efficacy and safety trial of asenapine for schizophrenia in adolescents has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia [Phase 4]
This Phase 4 trial compared melatonin to placebo to aid benzodiazepine discontinuation in patients with schizophrenia; the study has complet…
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia [Phase 4]
A Phase 4 clinical trial comparing atypical versus conventional antipsychotics for schizophrenia has completed. The brief does not include t…